The FDA Approved MONOVISC

 
  FDA okayed MONOVISC so they started m-

  arketing it immediately after. The suppleme-

  nt can be injected solely. MONOVISC helps 

  synovial fluid regarding the osteoarthritic joi-

  nt. After using it, the pain will subside & the 

  joints will be mobile again. 

 
  It’s marketed to patients that suffer from os-

  teoarthritis regarding knees. It’s the 1st FDA 

  approved sole-injection treatment with HA fr-

  om a source that does not utilize the anima-

  ls. The fluid is sterile, see-through, biocomp-

  atible, resorbable, and viscoelastic. 

 
  MONOVISC is also made of semi-cross-li-

   nked sodium hyaluronate (NaHA) in phosp-

   hate saline. The business DePuy Synthes 

   (Mitek Sports Medicine) is a great sports 

   medicine business. 

 
   Since 2008, the people at the company Ani-

   ka promoted MONOVISC worldwide. Viscos-

   upplementation therapy helped the United St-

   ates market grow twice. 

 
   MONOVISC is non-pyrogenic and it contains 

   high-molecular weight, mega-pure natural hy-

   aluronan. It is a complicated sugar and it was 

   born in the glycosaminoglycan group.
 
    The FDA viewed safety and effectiveness d-

    ata from a clinical study and it included 369 

    patients. They were within 31 centers throu-

    ghout the United States & Canada. 

   
    The research data convinced  the FDA that 

    MONOVISC’s adverse events stayed so low. 

    No large events occurred so the green light 

    was given.